ClinicalTrials.gov
ClinicalTrials.gov Menu

SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00412334
Recruitment Status : Completed
First Posted : December 18, 2006
Last Update Posted : April 5, 2016
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche